Review
References
Abay SM, Lucantoni L, Dahiya N, Dori G, Dembo EG, Esposito F, Lupidi G, Ogboi S, Ouédraogo RK, Sinisi A, Taglialatela-Scafati O, Yerbanga RS, Bramucci M, Quassinti L, Ouédraogo JB, Christophides G, Habluetzel A (2015). Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds. Malar. J. 14(1):288. |
|
Abbasi MM, Valizadeh H, Hamishehkar H, Zakeri-Milani P (2016). Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ. Res. Pharm. Sci. 11(3):177-186. |
|
Abena AA, Diatewa M, Gakossi G, Gbeassor M, Hondi-Assah TH, Ouamba JM (2003). Analgesic, antipyretic and anti-inflammatory effects of essential oil of Lippia multiflora. Fitoterapia 74(3):231-236. |
|
Ablordeppey SY, Hufford CD, Bourne RF, Dwuma-Badu D (1990). 1HNMR and 13C-NMR assignments of Cryptolepine, a 3:4 benzo-dcarboline derivative isolated from Cryptolepis sanguinolenta. Planta Med. 56(4):416-417. |
|
Abreu P, Pereira A (2001). New indole alkaloids from Sarcocephalus latifolius. Nat. Prod. Lett. 15(1):43-48. |
|
Addae-Mensah I, Waibel R, Achenbach H (1985). Constituents of West African Medicinal Plants, XVI. Novel Long-chain Triacylbenzenes from Cochlospermum planchonii. Liebigs Ann. Chem. 6:1284-1287 |
|
Adukondalu D, Shravan KY, Vamshi VY, Shiva KR, Madhusudan RY (2010). Effect of pomegranate juice pre-treatment on the transport of carbamazepine across rat intestine. Daru J. Facult. Pharm. Tehran Univ. Med. Sci. 18(4):254-259. |
|
Adzu B, Mustapha KB, Masimirembwa C, Obodozie O, Kirim RA, Gamaniel KS (2013). Simulation of metabolism-based herb-drug interaction: towards safe and efficacious use of NIPRD-AM1. Avicenna J. Phytomed. 3(3):201-204. |
|
Aliyu R, Okoye ZS, Shier WT (1995a). The hepatoprotective cytochrome P-450 enzyme inhibitor isolated from the Nigerian medicinal plant Cochlospermum planchonii is a zinc salt. J. Ethnopharmacol. 48(2):89-97. |
|
Aliyu R, Okoye ZSC, Shier TW (1995b). Cochlospermum planchonii rhizome extract with hepatoprotective activity inhibits cytochrome P-450 monooxygenases. Phytother. Res. 9(8):600-602. |
|
Anaga AO, Oparah NQ (2009). Investigation of the methanol root extract of Cochlospermum planchonii for pharmacological activities in vitro and in vivo. Pharm. Biol. 47(11):1027-1034. |
|
Araya S, Abera B, Giday M (2015). Study of plants traditionally used in public and animal health management in Seharti Samre District, Southern Tigray, Ethiopia. J. Ethnobiol. Ethnomed. 11:22. |
|
Asase A, Oteng-Yeboah AA, Odamtten GT, Simmonds MSJ (2005). Ethnobotanical study of some Ghanaian anti-malarial plants. J. Ethnopharmacol. 99(2):273-279. |
|
Ashour ML, Youssef FS, Gad HA, Wink M (2017). Inhibition of Cytochrome P450 (CYP3A4) activity by axtracts from 57 plants used in Traditional Chinese Medicine (TCM). Pharmacogn. Mag. 13(50):300-308. |
|
Audu SA, Taiwo AE, Ojuolape AR (2012). A study review of documented phytochemistry of Vernonia amygdalina (family asteraceae) as the basis for pharmacologic activity of plant extract. J. Med. Plants Res. 2(7):1-8. |
|
Azas N, Laurencin N, Delmas C, Di Giorgio C, Gasquet M, Laget M, Bahekar S, Kale R (2013). Herbal Plants Used for the Treatment of Malaria- A Literature Review. J. Pharmacogn. Phytochem. 1(6):141-146. |
|
Ballin NZ, Traore M, Tinto H, Sittie A, Mølgaard P, Olsen CE, Kharazmi A, Christensen SB (2002). Antiplasmodial compounds from Cochlospermum tinctorium. J. Nat. Prod. 65(9):1325-1327. |
|
Bandaranayake WM (2006). Quality control, screening, toxicity, and regulation of herbal drugs. In: Modern Phytomedicine. Turning Medicinal Plants into Drugs; Ahmad I, Aqil F, Owais M (eds.), (Weinheim: Wiley-VCH GmbH & Co. KGaA). pp. 25-57. Available at: |
|
Bangou MJ, Almaraz-Abarca N, Méda NTR, Zeba B, Kiendrebeogo M, Millogo-Rasolodimby J Nacoulma OG (2012a). Polyphenolic composition of Lantana camara and Lippia chevalieri, and their antioxidant and antimicrobial activities. Int. J. Phytomed. 4:115-124. |
|
Bangou MJ, Kiendrebeogo M, Compaore M, Coulibay AY, Meda NR., Abraca NA., Zeba B., Millogo-Rasolodimby J., Nacoulma OG (2011). Enxyme Inhibition effect and polyphenolic content of medicinal plant extract from Burkina Faso. J. Biol. Sci. 11(1):31-38. |
|
Bangou MJ, Norma AA, Meda RN, Yougbaré-Ziébrou M, MillogoRasolodimby J, Nacoulma OG (2012b). Lippia chevalieri Moldenke: A brief review of traditional uses, phytochemistry and pharmacology. Int. J. Drug Deliv. 4(3):289-296. |
|
Bansal T, Jaggi M, Khar RK, Talegaonkar S (2009). Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J. Pharm. Pharm. Sci. 12(1):46-48. |
|
Bapna S, Choudhary PK, Ramaiya M, Chowdhary A (2015). Antiplasmodial activity af Argemone Mexicana: An in vivo and in vitro study. World J. Pharm. Res. 4(11):1653-1663. |
|
Barbosa AF, de Carvalho MG, Smith RE, Sabaa-Srur AUO (2016). Spilanthol: occurrence, extraction, chemistry and biological activities. Rev. Bras. Farm. 26:128-133. |
|
Bardia A, Nisly NL, Zimmerman MB, Gryzlak BM, Wallace RB (2007). Use of herbs among adults based on evidence-based indications: Findings from the National Health Interview Survey. Mayo Clinic Proceed. 82(5):561-566. |
|
Barku VYA, Opoku-Boahen Y, Dzotsi EY (2012). Isolation and pharmacological activities of alkaloids from Cryptolepis sanguinolenta (Lindl) schlt. Int. Res. J. Biochem. Bioinform. 2(3):58-61. |
|
Bassole IHN, Ouattara AS, Nebie R, Ouattara AT, Kabore ZI, and Traore SA (2003). Chemical composition and antibacterial activities of the essential oils of Lippia chevalieri and Lippia multiflora from Burkina Faso. Phytochemistry 62(2):209-212. |
|
Benoit-Vical F, Valentin A, Da B, Dakuyo Z, Descamps L, Mallié M (2003). N'Dribala (Cochlospermum planchonii) versus chloroquine for treatment of uncomplicated Plasmodium falciparum malaria. J. Ethnopharmacol. 89(1):111-114. |
|
Benoit-Vical F, Valentin A, Mallie M Bessiere J (2001). Antiplasmodial activity of Cochlospermum planchonii and C. tinctorium Tubercle essential oils. J. Essent. Oil Res. 13(1):65-67. |
|
Benoit-Vical F, Valentin A, Mallié M, Bastide JM, Bessière JM (1999). In vitro antimalarial activity and cytotoxicity of Cochlospermum tinctorium and C. planchonii leaf extracts and essential oils. Planta Med. 65(4):378-381. |
|
Bhakuni R, Jain D, Sharma R (2002). Phytochemistry of Artemisia annua and the development of artemisinin-derived antimalarial agents. In: Wright C, editor. Artemisia. London: Taylor & Francis. |
|
Bhattacharya D (2011). Fight malaria at home: Therapeutic and prophylaxis clinical data. Asian Pac. J. Trop. Dis. 1(2):142-149. |
|
Bhattacharya D, Bhuyan BM, Pradhan PK, Nayak DK (2013). Transmission blocking of year-round resistant malaria in Koraput (India) by OMARIA – A New Antimalarial Phytotherapy. Br. J. Pharm. Res. 3(1):54-77. |
|
Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G (2003). The conduct of in vitro and in vivo drugâ€drug interaction studies: A PhRMA perspective. J. Clin. Pharmacol. 43(5):443-469. |
|
Bugyei KA, Boye GL, Addy ME (2010). Clinical efficacy of a tea-bag formulation of Cryptolepis sanguinolenta root in the treatment of acute uncomplicated falciparum malaria. Ghana Med. J. 44(1):3-9. |
|
Camacho MDR, Phillipson JD, Croft SL, Yardley V, Solis PN (2004). In vitro antiprotozoal and cytotoxic activities of some alkaloids, quinones, flavonoids, and coumarins. Planta Med. 70(1):70-72. |
|
Challand S, Willcox M (2009). A clinical trial of the traditional medicine Vernonia amygdalina in the treatment of uncomplicated malaria. J. Altern. Complement. Med. 15(11):1231-1237. |
|
Cho HJ, Yoon IS (2015). Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein. J. Evid. Based Complement. Altern. Med. 2015:736431. |
|
Choi JS, Choi I, Choi DH (2013). Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and p-glycoprotein inhibition by nifedipine. Pharmacol. Rep. 65(5):1422-1430. |
|
Choi YH, Lee MG (2012). Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes. Xenobiotica 42(5):483-495. |
|
Choudhary PK, Nagori BP (2014). Evaluation of in vitro antimalarial activity of Cassia occidentalis. World J. Pharm. Pharm. Sci. 3(2):2241-2248. |
|
Christensen SB, Kharazmi A (2001). Antimalarial natural products. Isolation, characterisation and biological properties. In: Tringali C (Ed.), Bioactive Compounds from Natural Sources. Taylor & Francis, London and New York. pp. 379-432. |
|
Cimanga K, De Bruyne T, Pieters L, Vlietinck AJ, Turger CA (1997). In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta. J. Nat. Prod. 60(7):688-691. |
|
Clarkson C, Maharaj VJ, Crouch NR, Grace OM, Pillay P, Matsabisa MG, Bhagwandin N, Smith PJ, Folb PI (2004). In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa. J. Ethnopharmacol. 92(2-3):177-191. |
|
Cui L, Mharakurwa S, Ndiaye D, Rathod PK, Rosenthal PJ (2015). Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network. Am. J. Trop. Med. Hyg. 93(Suppl 3):57-68. |
|
Dakuyo Z, Lamien-Meda A, Da O, Kiendrebeogo M, Traoré-Coulibaly M, Novak J, Benoit-Vical F, Weisbord E, Willcox M (2015). SAYE: The story of an antimalarial phytomedicine from Burkina Faso.J. Altern. Complement. Med. 21(4):187-195. |
|
Das M, Samra BP (2017). Clinical trial of G. neivum as anti-malarial drug in Malaria. J. Sci. 2(4):9-12. |
|
de Lima M, Vieira T, Huang SM (2012). Botanical-drug interactions: a scientific perspective. Planta Med. 78(13):1400-1415. |
|
Dell'Agli M, Galli GV, Corbett Y, Taramelli D, Lucantoni L, Habluetzel A, Maschi O, Caruso D, Giavarini F, Romeo S, Bhattacharya D, Bosisio E (2009). Antiplasmodial activity of Punica granatum L. fruit rind. J. Ethnopharmacol. 125(2):279-285. |
|
Deshpande HA, Bhalsing SR (2013). Recent advances in the phytochemistry of some medicinally important cassia species: a review. Int. J. Pharm. Med. Biol. Sci. 2(3):61-78. |
|
Diallo B, Vanhaelen M (1987). Apocarotenoids from Cochlospermum tinctorium. Phytochemistry 26(5):1491-1492. |
|
Diallo D, Maiga A, Diakite C, Willcox M (2004). Malarial-5: Development of an antimalarial phytomedicine in Mali. In: Willcox M, Bodeker G, Rasoanaivo P (eds.), Traditional medicinal plants and malaria. Boca Raton: CRC Press; 2004. |
|
Diarra N, Klooster CV, Jong J, de Togola A, Diallo D, Willcox M (2015). Ethnobotanical study of plants used against malaria in Selingue subdistrict, Mali. J. Ethnopharmacol. 166:352-360. |
|
Dju A, Nilsen OG, Steinsbekk A (2013). The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study. BMC Complement. Altern. Med. 13:295. |
|
Donkor AF (2016). Efficacy, pharmacokinetics and safety evaluation of cryptolepine-artemisinin based combinations in the management of uncomplicated malaria," PhD Thesis, Kwame Nkrumah University of Science and Technology. |
|
Doumbia S (1997). Etude des plantes antipaludiques au Mali. Bamako: Universite de Bamako, Faculte de Medecine, Pharmacie et Odonto-Stomatolo-gie, 78. |
|
Dubey S, Maity S, Singh M, Saraf SA, Saha S (2013). Phytochemistry, Pharmacology and Toxicology of Spilanthes acmella: A review. Adv. Pharmacol. Sci. 2013:423750. |
|
Egharevba C, Osayemwenre E, Imieje V, Ahomafor J, Akunyuli C, Udu- Cosi AA, Theophilus O, James O, Ali I, Falodu A (2014). Significance of bitter leaf (Vernonia amagdalina) in tropical diseases and beyond: A Review. Malar. Chemoth. Cont. 3:120. |
|
Ekor M (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 4(177):1-9. |
|
Elango H, Ponnusankar S, Sundaram S (2015). Assessment of Pharmacodynamic and Pharmacokinetic Interaction of Aqueous Extract of Cassia auriculata L. and Metformin in Rats. Pharmacogn. Mag. 11(Suppl 3):S423-S426. |
|
Erasto P, Grierson DS, Afolayan AJ (2006). Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J. Ethnopharmacol. 106(1):117-120. |
|
Ernst E, White A (2000). The BBC survey of complementary medicine use in the UK. Complement. Ther. Med. 8(1):32. |
|
Eruvaram NR, Das M (2009). Phenotype of hepatic xenobiotic metabolizing enzymes and CYP450 isoforms of sanguinarine treated rats: effect of P450 inducers on its toxicity. Toxicol. Mechanisms Methods 19(8):510-517. |
|
Eseyin AO, Igboasoiyi CA, Igbo C, Igboasoiyi A, Ekarika J, Dooka B (2012). Effects of the leaf extract of Venonia amygdalina on the pharmacokinetics of dihydroartemisinin in rat. Pharmacologia 3(12):713-718. |
|
Etiaba E, Onwujekwe O, Uzochukwu B, Uguru N, Okoronkwo I, Adjagba A (2015). What co-morbidities do people with malaria have and what are their patterns of health seeking in Nigeria? Niger. J. Clin. Pract. 18(1):22-26. |
|
Faria A, Monteiro R, Azevedo I, Calhau C (2007). Pomegranate Juice Effects on Cytochrome P450s Expression: In Vivo Studies. J. Med. Food. 10(4):643-649 |
|
Fasinu PS, Manda VK, Dale OR, Egiebor NO, Walker LA, Khan S (2016). Evaluation of the influence of selected herbal extracts on the activity of p-glycoprotein and pregnane X receptor activation. Planta Med. 82(05):PB13. |
|
Forkuo AD, Ansah C, Boadu KM, Boampong JN, Ameyaw EO, Gyan BA, Arku AT, Ofori MF (2016). Synergistic anti-malarial action of cryptolepine and artemisinins. Malar. J. 15:89. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0